Dr Elise Feng-I Morgan of Boston University receives 2005 IOF-Servier Young Investigator Award

June 05, 2006

Dr Elise Feng-i Morgan, of Boston University, today received the prestigious 2005 IOF-Servier Young Investigator Award, during the 2006 IOF World Congress on Osteoporosis (IOF WCO) in Toronto, Canada. Dr Morgan, who is Assistant Professor of Aerospace and Mechanical Engineering, at Boston University, USA, won this award for her proposal to use three-dimensional visualization to understand how spine fractures start and progress, and then to test models to predict vertebral fracture. "Dr Feng-i Morgan's project to use the latest techniques from aerospatial and mechanical engineering to understand how vertebrae fracture, caught the judges attention as it will contribute to widening our knowledge of osteoporosis," said Professor Pierre Delmas, President, International Osteoporosis Foundation.

The IOF-Servier Young Investigator Award helps to increase awareness and understanding of osteoporosis and to encourage young scientists, under the age of 40, to continue their work in this field. The award is supported by the Servier Research Group in partnership with IOF, providing Euro 40,000 towards original research of significant value and international relevance in the field of osteoporosis.

More than 30 entries were received for the 2005 IOF-Servier Young Investigator Award.
-end-
Osteoporosis, in which the bones become porous and break easily, is one of the world's most common and debilitating diseases. The result: pain, loss of movement, inability to perform daily chores, and in many cases, death. One out of three women over 50 will experience osteoporotic fractures, as will one out of five men 1, 2, 3.

Unfortunately, screening for people at risk is far from being a standard practice. Osteoporosis can, to a certain extent, be prevented, it can be easily diagnosed and effective treatments are available.

The International Osteoporosis Foundation (IOF) is the only worldwide organization dedicated to the fight against osteoporosis. It brings together scientists, physicians, patient societies and corporate partners. Working with its 172 member societies in 85 locations, and other healthcare-related organizations around the world, IOF encourages awareness and prevention, early detection and improved treatment of osteoporosis.

1 Melton U, Chrischilles EA, Cooper C et al. How many women have osteoporosis? Journal of Bone Mineral Research, 1992; 7:1005-10
2 Kanis JA et al. Long-term risk of osteoporotic fracture in Malmo. Osteoporosis International, 2000; 11:669-674
3. Melton LJ, et al. Bone density and fracture risk in men. JBMR. 1998; 13:No 12:1915

IOF World Congress on Osteoporosis, held every two years, is the only global congress dedicated specifically to all aspects of osteoporosis. Besides the opportunity to learn about the latest science and developments in diagnosis, treatment and the most recent socio-economic studies, participants have the chance to meet and exchange ideas with other physicians from around the world. All aspects of osteoporosis will be covered during the Congress which will comprise lectures by invited speakers presenting cutting edge research in the field, 35 oral presentations and more than 680 poster presentation selected from 720 submitted abstracts. More than 70 Meet the Expert Sessions covering many practical aspects of diagnosis and management of osteoporosis are also on the program.

For more information on osteoporosis and IOF please visit: www.osteofound.org

For further information, please contact: Paul Spencer Sochaczewski, Head of Communications,
International Osteoporosis Foundation:
Tel. +41 22 994 0100 - Fax. +41 22 994 0101 - E-mail: IOFnews@osteofound.org
or
Andrew Leopold, Weber Shandwick Worldwide
400-207 Queen's Quay West, Toronto, Tel: +1 416 964 6444
E-mail: aleopold@webershandwick.com

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.